Comparer des méthodes

	Questionnaire abrégé sur les maladies inflammatoires de l'intestin	Indice Simple d'Activité Clinique de la Colite
Domaine	Gastro-entérologie	Gastro-entérologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	2004	1998
Auteur d'origine	Guyonnet, D., Chassany, O., Ducroc, R., et al.	Walmsley, R. S., Ayres, R. C., Pounder, R. E., and Allan, R. N.
Type	Self-report	Clinician-rated
Source fondatrice	Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465.	Walmsley, R. S., Ayres, R. C., Pounder, R. E., & Allan, R. N. (1998). A simple clinical colitis activity index. Gut, 43(1), 29–32.
Alias	IBDQ-32, Short IBDQ	SCCAI
Apparentées	4	4
Résumé	The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.	The Simple Clinical Colitis Activity Index (SCCAI) is a practical, bedside tool for assessing disease activity in ulcerative colitis and colonic Crohn's disease. Published in 1998 by Walmsley and colleagues, the SCCAI condenses disease assessment into six items that can be administered in a office visit without laboratory or endoscopic data. It provides rapid, reproducible quantification of disease severity and is ideal for frequent monitoring in routine clinical practice.